Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Jon C. Ogg | Nov 21, 2011 at 8:38 AM EST

Another Bump Up for Dendreon and PROVENGE (DNDN)

Dendreon Corporation (NASDAQ: DNDN) is surging on news that the Centers for Medicare and Medicaid Services will now cover the…

Jon C. Ogg | Nov 21, 2011 at 7:51 AM EST

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Gilead Sciences Inc. (NASDAQ: GILD) is trading lower on news that it is spending some $11 billion to buy Pharmasset,…

David J. Phillips | Nov 17, 2011 at 1:45 PM EST

Dendreon Buyout, How Imminent?

Though near-term growth visibility for its cancer vaccine Provenge remains cloudy, Seattle-based Dendreon (DNDN) could be an attractive takeover candidate…

Douglas A. McIntyre | Nov 16, 2011 at 6:24 AM EST

America’s Psychiatric Drug Addition

“Sell crazy someplace else; we’re all stocked up here,” says Jack Nicholson in 1997’s As Good as It Gets. There…

Douglas A. McIntyre | Nov 10, 2011 at 6:28 AM EST

Walmart Denies Plans for Health Care Network, Even as Clinics Thrive

Walmart (NYSE: WMT) said that the press was mistaken when several media reported the world’s largest retailer would create a national…

Jon C. Ogg | Nov 7, 2011 at 10:04 AM EST

Vertex RA Study: When Good Is Not Good Enough (VRTX)

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) might have sounded as though shares would be up Monday morning if you were just…

Douglas A. McIntyre | Nov 5, 2011 at 11:07 AM EDT

The Eight Drug Shortages Putting Americans at Risk

President Obama this week signed an executive order directing federal regulators to address shortages of vital prescription drugs. According to…

Jon C. Ogg | Nov 3, 2011 at 10:59 AM EDT

Medivation, A Pain in the Rear for Dendreon (MDVN, DNDN)

Medivation, Inc. (NASDAQ: MDVN) is today’s darling in biotech and emerging pharmaceuticals. It and partner Astellas in Japan showed very…

Douglas A. McIntyre | Nov 2, 2011 at 6:19 AM EDT

Economics of Painkiller Abuse

The regions of the U.S. in which painkiller use is extremely high also tend to be the poorest sections of…

Jon C. Ogg | Oct 25, 2011 at 8:55 AM EDT

Healthways: The Implosion of the Day (HWAY, CI)

Healthways Inc. (NASDAQ: HWAY) could be named “The Implosion Stock of the Day.” Revenues rose 3.3% from a year earlier to…

Douglas A. McIntyre | Oct 25, 2011 at 6:24 AM EDT

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work…

Jon C. Ogg | Oct 24, 2011 at 10:24 AM EDT

Endless Mergers… More to Come! (CBST, ADLR, HS, CI, CVH, MAT, RNOW, ORCL, SLE, SJM, ANDS, NYX)

Monday is called “Merger Monday” for a reason and this morning is a classic example of its namesake. We have…

Paul Ausick | Oct 20, 2011 at 10:58 AM EDT

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…

Jon C. Ogg | Oct 19, 2011 at 11:34 AM EDT

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

We have compiled a detailed list of expected upside in the biotech sector. The sector has consolidated and now there…

Jon C. Ogg | Oct 19, 2011 at 10:18 AM EDT

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public. So what…

1 … 324 325 326 327 328 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Another Bump Up for Dendreon and PROVENGE (DNDN)

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Dendreon Buyout, How Imminent?

America’s Psychiatric Drug Addition

Walmart Denies Plans for Health Care Network, Even as Clinics Thrive

Vertex RA Study: When Good Is Not Good Enough (VRTX)

The Eight Drug Shortages Putting Americans at Risk

Medivation, A Pain in the Rear for Dendreon (MDVN, DNDN)

Economics of Painkiller Abuse

Healthways: The Implosion of the Day (HWAY, CI)

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Endless Mergers… More to Come! (CBST, ADLR, HS, CI, CVH, MAT, RNOW, ORCL, SLE, SJM, ANDS, NYX)

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Health and Healthcare Articles

All Health and Healthcare Articles

Another Bump Up for Dendreon and PROVENGE (DNDN)

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Dendreon Buyout, How Imminent?

America’s Psychiatric Drug Addition

Walmart Denies Plans for Health Care Network, Even as Clinics Thrive

Vertex RA Study: When Good Is Not Good Enough (VRTX)

The Eight Drug Shortages Putting Americans at Risk

Medivation, A Pain in the Rear for Dendreon (MDVN, DNDN)

Economics of Painkiller Abuse

Healthways: The Implosion of the Day (HWAY, CI)

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Endless Mergers… More to Come! (CBST, ADLR, HS, CI, CVH, MAT, RNOW, ORCL, SLE, SJM, ANDS, NYX)

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation